Repligen and Univercells Technologies have partnered to embed real-time glucose and lactate monitoring within Univercells' scale-X bioreactors. The integration of Repligen’s MAVEN platform enables continuous metabolic control without removing media, providing up to 720 data points per day. This advance enhances viral vector and vaccine production by facilitating precise nutrient management and cell growth estimation, improving bioprocess optimization for commercial-grade manufacturing.